Literature DB >> 12044636

Analysis of synphilin-1 and synuclein interactions by yeast two-hybrid beta-galactosidase liquid assay.

Michael Neystat1, Margarita Rzhetskaya, Nikolai Kholodilov, Robert E Burke.   

Abstract

Synphilin-1 interacts with alpha-synuclein, which has been implicated in the pathogenesis of Parkinson's disease (PD). By examination of their interactions quantitatively, with the use of the yeast two-hybrid beta-galactosidase assay, we find that the synuclein amino acid (aa) 1-65 region is sufficient for an interaction. A central domain of synphilin-1, aa 349-555, is both necessary and sufficient for an interaction with alpha-synuclein. We did not observe an effect of the synuclein A53T mutation, which causes one familial form of PD, on interactions with synphilin-1. However, the A30P mutation caused an increase in the interaction between the synuclein aa 1-65 fragment and the synphilin-1 central domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044636     DOI: 10.1016/s0304-3940(02)00253-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.

Authors:  Blanca A Silva; Leonid Breydo; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-09-01       Impact factor: 5.590

Review 2.  Environmental toxins and alpha-synuclein in Parkinson's disease.

Authors:  Yanying Liu; Hui Yang
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

4.  Synphilin-1 inhibits alpha-synuclein degradation by the proteasome.

Authors:  Beatriz Alvarez-Castelao; José G Castaño
Journal:  Cell Mol Life Sci       Date:  2010-11-20       Impact factor: 9.261

5.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Jordi Humbert; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2008-03-12       Impact factor: 2.660

7.  Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.

Authors:  Esti Liani; Allon Eyal; Eyal Avraham; Revital Shemer; Raymonde Szargel; Daniela Berg; Antje Bornemann; Olaf Riess; Christopher A Ross; Ruth Rott; Simone Engelender
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

Review 8.  S-nitrosylation of the thioredoxin-like domains of protein disulfide isomerase and its role in neurodegenerative conditions.

Authors:  Myra E Conway; Matthew Harris
Journal:  Front Chem       Date:  2015-04-16       Impact factor: 5.221

Review 9.  Molecular pathology of Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Aurelio Ariza
Journal:  Int J Mol Sci       Date:  2009-02-26       Impact factor: 5.923

10.  Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.

Authors:  James M Gruschus
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.